FREM1 and breast carcinoma: Recently, many studies have shown that FREM1 can be used as a new therapeutic target and prognostic marker for breast cancer and the increase in its expression is related to the high level of infiltration of anti-tumor immune cells (Xu et al., 2020a; Li et al., 2020; Zhang et al., 2020).